Premium
Superiority of endoscopic interventions over minimally invasive surgery for infected necrotizing pancreatitis: meta‐analysis of randomized trials
Author(s) -
Bang Ji Young,
Wilcox Charles Melbern,
Arnoletti Juan Pablo,
Varadarajulu Shyam
Publication year - 2020
Publication title -
digestive endoscopy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.5
H-Index - 56
eISSN - 1443-1661
pISSN - 0915-5635
DOI - 10.1111/den.13470
Subject(s) - medicine , pancreatitis , perforation , randomized controlled trial , pancreatic fistula , endoscopy , surgery , therapeutic endoscopy , gastroenterology , pancreas , materials science , punching , metallurgy
Background and Aim Infected necrotizing pancreatitis is a highly morbid disease managed by minimally invasive surgical (MIS) or endoscopy‐based interventions. This meta‐analysis compared the clinical outcomes of patients treated using either approach. Methods MEDLINE and EMBASE databases were searched to identify all randomized trials that compared MIS and endoscopy‐based interventions for treatment of infected necrotizing pancreatitis. Main outcome measure was to compare rates of complications or death during 6‐month follow‐up. Results Three studies involving 184 patients met inclusion criteria. While there was no significant difference in mortality (14.5% vs. 16.1%, risk ratio [RR] = 1.02, P = 0.963), new onset multiple organ failure (5.2% vs. 19.7%, RR = 0.34, P = 0.045), enterocutaneous fistula/perforation (3.6% vs. 17.9%, RR = 0.34, P = 0.034) and pancreatic fistula (4.2% vs. 38.2%, RR = 0.13, P < 0.001) were significantly lower for endoscopic interventions compared to MIS . There was no significant difference in intraabdominal bleeding, endocrine or exocrine pancreatic insufficiency between cohorts. Length of hospital stay was significantly shorter for endoscopy (standardized mean difference, −0.41, P = 0.010). Conclusions An endoscopy‐based treatment approach, as compared to minimally invasive surgery, significantly reduces complications in patients with infected necrotizing pancreatitis.